Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1

Status

Recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3Gastrointestinal 1

Conditions

Breast Neoplasms 3Osteoporosis 1Motor Activity 1Inflammation 1Colonic Neoplasms 1Bone Diseases, Metabolic 1

Interventions

pembrolizumab 1265Specimen Handling 926Magnetic Resonance Spectroscopy 830Carboplatin 823Cyclophosphamide 800Cisplatin 723Nivolumab 669Paclitaxel 627Radiotherapy 611Gemcitabine 573Biopsy 557Bevacizumab 478Dexamethasone 438fludarabine 407Docetaxel 380venetoclax 368Oxaliplatin 364Capecitabine 358Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 330Drug Therapy 326Doxorubicin 316Radiosurgery 315Standard of Care 309Blood Specimen Collection 308Pemetrexed 305Ipilimumab 299Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Calcium × 1 year × Clear all
NCT07534852 2026-04-16

NIMA

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Phase NA Recruiting
120 enrolled
Gastrointestinal

Colonic Neoplasms, Inflammation, Motor Activity

NCT04067726 2026-03-31

TRIDENT

Washington University School of Medicine

Phase 2 Active not recruiting
210 enrolled
Breast

Breast Neoplasms

NCT01480869 2026-03-12

VITACAL

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 3 Completed
215 enrolled
Breast

Breast Neoplasms

NCT07334626 2026-01-15

PilatesBCS2026

Benha University

Phase NA Recruiting
60 enrolled
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡